Trading at a 9.9% gross spread, below where it was trading before the lawsuit. On balance, this Offer gets up. But run the deal specifics via a pharma lawyer to gain greater comfort on the lawsuit.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.